USNA
USANA HEALTH SCIENCES INC
NYSE · Consumer Defensive · Packaged Foods · US
$14.22
−4.37%Income statement
| Metric | TTM | 2026 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 905.6M | 925.3M | 854.5M | 921.0M | 998.6M |
| Cost of Revenue | 205.9M | 200.9M | 175.8M | 189.4M | 207.3M |
| Gross Profit | 699.7M | 724.4M | 678.8M | 731.6M | 791.3M |
| Operating Expenses | |||||
| R&D Expense | — | — | 11.6M | 11.4M | 11.6M |
| SG&A Expense | 335.4M | 337.4M | 600.9M | 627.1M | 672.1M |
| General & Admin Expense | 78.1M | 337.4M | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 305.9M | 336.2M | — | — | — |
| Total Operating Expenses | 641.3M | 673.5M | 612.4M | 638.5M | 683.7M |
| Cost and Expenses | 847.2M | 874.4M | 788.2M | 827.9M | 891.0M |
| Operating Income (EBIT) | 9.7M | 50.9M | 66.3M | 93.1M | 107.6M |
| Non-Operating | |||||
| Interest Income | 2.2M | 2.4M | 11.3M | 9.6M | 3.8M |
| Interest Expense | 325.0K | 842.0K | 281.0K | 262.0K | 192.0K |
| Net Interest Income | 1.2M | 1.6M | 11.0M | 9.4M | 3.6M |
| Other Non-Op Income/Expense | (9.7M) | (9.3M) | 10.0M | 9.4M | 1.0M |
| Non-Operating Income (excl Interest) | 10.0M | 8.5M | (10.3M) | (9.6M) | (1.2M) |
| EBT (Pre-Tax Income) | (62.0K) | 41.5M | 76.4M | 102.5M | 108.6M |
| Income Tax Expense | 28.1M | 30.1M | 34.3M | 38.7M | 39.3M |
| Bottom Line | |||||
| Net Income | (21.2M) | 10.8M | 42.0M | 63.8M | 69.3M |
| Earnings from Cont. Ops | (28.1M) | 11.5M | 42.1M | 63.8M | 69.3M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (21.2M) | 10.8M | 42.0M | 63.8M | 69.3M |
| Per Share | |||||
| Basic EPS | ($1.15) | $0.58 | $2.20 | $3.33 | $3.60 |
| Diluted EPS | ($1.15) | $0.58 | $2.19 | $3.30 | $3.59 |
| Revenue Per Share | $48.96 | $49.81 | $44.82 | $47.84 | $51.86 |
| Shares | |||||
| Basic Shares Outstanding | 18.5M | 18.6M | 19.1M | 19.3M | 19.3M |
| Diluted Shares Outstanding | 18.5M | 18.6M | 19.2M | 19.3M | 19.3M |
| Profitability Metrics | |||||
| EBITDA | 28.9M | 82.1M | 98.9M | 123.1M | 130.2M |
| D&A | 29.2M | 39.7M | 22.2M | 20.4M | 21.4M |
| EBIT | 1.1M | 42.4M | 76.6M | 102.7M | 108.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Oct 1, 2026